Authors:
COBELLI S
SCANNI A
BATTELLI T
PISONE A
FRONTINI L
DILULLO L
MATTIOLI R
Citation: S. Cobelli et al., VINORELBINE (VNR) PLUS 5-FLUOROURACIL CONTINUOUS-INFUSION (5-FU CI) IN PRETREATED ADVANCED BREAST-CANCER - ADRIA MEDICA GROUP, European journal of cancer, 34, 1998, pp. 62-62
Authors:
TOMIROTTI M
GALASSI B
DAMBROSIO M
FOSSATI V
GRAMEGNA G
COLOMBO F
ROVEJ R
SCANNI A
Citation: M. Tomirotti et al., CIS CARBOPLATIN PLUS VINORELBINE +/- RADIOTHERAPY IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CARCINOMA/, Journal of chemotherapy, 9(1), 1997, pp. 62-65
Authors:
BAJETTA E
DIBARTOLOMEO M
SOMMA L
MORESCHI M
COMELLA G
TURCI D
GEBBIA V
SCANNI A
BORDOGNA G
STAMPINO CG
Citation: E. Bajetta et al., RANDOMIZED PHASE-II NONCOMPARATIVE TRIAL OF ORAL AND INTRAVENOUS DOXIFLURIDINE PLUS LEVO-LEUCOVORIN IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Cancer, 78(10), 1996, pp. 2087-2093
Authors:
MANTICA C
LAVERDE N
FARINA G
COBELLI S
DAMBROSIO M
PERRONE S
TOMIROTTI M
SCANNI A
Citation: C. Mantica et al., TAMOXIFEN (TAM) IN BREAST-CANCER (BC) - TOXICITY OF LONG-TERM ADJUVANT TREATMENT, European journal of cancer, 31A, 1995, pp. 59-59
Authors:
SILVA F
PERRONE S
SALA A
FARINA G
SCANNI A
Citation: F. Silva et al., SURVIVAL OF PATIENTS WITH LIVER METASTASES OF COLORECTAL ORIGIN TREATED WITH PERCUTANEOUS ETHANOL INJECTION (PEI) WITH OR WITHOUT SURGERY, European journal of cancer, 31A, 1995, pp. 749-749
Authors:
TOMIROTTI M
DIMAIUTA M
CONFALONIERI M
SCANNI A
Citation: M. Tomirotti et al., EFFICACY AND TOLERABILITY OF NASALLY ADMINISTERED COMPARED TO PARENTERALLY ADMINISTERED METOCLOPRAMIDE IN THE SYMPTOMATIC TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS IN CANCER OUTPATIENTS - A CONTROLLED CLINICAL-STUDY, Supportive care in cancer, 2(6), 1994, pp. 389-392
Authors:
SPINAZZI A
SORESI E
BOFFI R
NONIS A
NOSEDA A
COBELLI S
SCANNI A
Citation: A. Spinazzi et al., EVALUATION OF NEURON-SPECIFIC ENOLASE, TISSUE POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN AS MARKERS FOR STAGING AND MONITORING RESPONSE TO THERAPY OF LUNG-CANCER, Cancer detection and prevention, 18(3), 1994, pp. 209-220
Authors:
MUSTACCHI G
MILANI S
PLUCHINOTTA A
DEMATTEIS A
RUBAGOTTI A
PERROTA A
BOLOGNESI A
BONI C
CACIOPPO C
CECCHERINI R
FARRIS A
GAMBROSIER P
GARATTINI P
MAIORINO L
SANTORO A
SCANNI A
SCHIEPPATI G
SISMONDI P
TRAINA A
TARQUINI A
ZADRO A
Citation: G. Mustacchi et al., TAMOXIFEN OR SURGERY PINS TAMOXIFEN AS PRIMARY-TREATMENT FOR ELDERLY PATIENTS WITH OPERABLE BREAST-CANCER - THE GRETA TRIAL, Anticancer research, 14(5B), 1994, pp. 2197-2200
Authors:
TOMIROTTI M
BERNARDO G
EPIFANI C
BIASIOLI R
FRANCHI R
MENSI F
CARNAGHI P
SCHIEPPATI G
SCANNI A
Citation: M. Tomirotti et al., RECOVERY OF RESPONSE TO ADRIAMYCIN AND CYCLOPHOSPHAMIDE BY LONIDAMINEIN PREVIOUSLY TREATED METASTATIC BREAST-CANCER PATIENTS, International journal of oncology, 3(2), 1993, pp. 213-217
Authors:
BAJETTA E
COLLEONI M
ROSSO R
SOBRERO A
AMADORI D
COMELLA G
MARANGOLO M
SCANNI A
LORUSSO V
CALABRESI F
BONSIGNORI M
CRIVELLARI D
PASQUINI E
BRUZZI P
REPETTO M
CRISCUOLO D
Citation: E. Bajetta et al., PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 29A(12), 1993, pp. 1658-1663
Authors:
TOMIROTTI M
GRAMEGNA G
MANTELLINI P
FOSSATI V
MEZZETTI M
DIMAIUTA M
SCANNI A
Citation: M. Tomirotti et al., CONCURRENT CARBOPLATIN (CBDCA), VINDESINE (VDS) AND RADIOTHERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER (NSCLC), Tumori, 79(1), 1993, pp. 49-57
Authors:
BAJETTA E
ZILEMBO N
DIBARTOLOMEO M
DILEO A
PILOTTI S
BOCHICCHIO AM
CASTELLANI R
BUZZONI R
CELIO L
DOGLIOTTI L
PINOTTI G
AITINI E
LABIANCA R
FORNASIERO A
RIVA P
SCHIEPPATI G
NELLI P
MARIANI L
ATTARD M
BARDUAGNI M
BELLU F
BUZZI F
DAPRILE M
DEMARINO E
EPIFANI C
FARINA G
FATTORI PP
FERRERO B
FOSSER V
IIRILLO A
LORUSSO V
MAIFREDI G
MEROZZI P
PASINI F
SARTI EL
SCANNI A
VERUSIO C
VILLA E
Citation: E. Bajetta et al., TREATMENT OF METASTATIC CARCINOIDS AND OTHER NEUROENDOCRINE TUMORS WITH RECOMBINANT INTERFERON-ALPHA-2A - A STUDY BY THE ITALIAN TRIALS IN MEDICAL ONCOLOGY GROUP, Cancer, 72(10), 1993, pp. 3099-3105
Authors:
SCAGLIONE F
SCANNI A
TOMIROTTI M
DIMAIUTA M
FERRARI P
FRASCHINI F
Citation: F. Scaglione et al., PHARMACOKINETICS AND BIOAVAILABILITY OF METOCLOPRAMIDE NASAL SPRAY VERSUS METOCLOPRAMIDE INTRAVENOUS IN HEALTHY-VOLUNTEERS AND CANCER-PATIENTS, Arzneimittel-Forschung, 43-2(9), 1993, pp. 986-988